{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:27:48Z","timestamp":1794407268257,"version":"4.9.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH","award":["EB000768"],"award-info":[{"award-number":["EB000768"]}]},{"name":"National Institute of Health","award":["S10 RR025645"],"award-info":[{"award-number":["S10 RR025645"]}]},{"DOI":"10.13039\/100000957","name":"Alzheimer Association","doi-asserted-by":"crossref","award":["IIRG-11-205935"],"award-info":[{"award-number":["IIRG-11-205935"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH-MARC U*STAR","award":["5T34GMO92711-04"],"award-info":[{"award-number":["5T34GMO92711-04"]}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG044263"],"award-info":[{"award-number":["R01 AG044263"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13024-017-0169-9","type":"journal-article","created":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T18:24:45Z","timestamp":1490120685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":163,"title":["Soluble oligomeric amyloid-\u03b2 induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain"],"prefix":"10.1186","volume":"12","author":[{"given":"Michal","family":"Arbel-Ornath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloise","family":"Hudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiah R.","family":"Boivin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadafumi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuko","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishore V.","family":"Kuchibhotla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carli R.","family":"Lattarulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna M.","family":"Belcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Shakerdge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pariss B.","family":"Trujillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alona","family":"Muzikansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Betensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley T.","family":"Hyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Bacskai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,21]]},"reference":[{"key":"169_CR1","doi-asserted-by":"publisher","first-page":"7278","DOI":"10.1523\/JNEUROSCI.1879-05.2005","volume":"25","author":"TL Spires","year":"2005","unstructured":"Spires TL, Meyer-Luehmann M, Stern EA, McLean PJ, Skoch J, Nguyen PT, Bacskai BJ, Hyman BT. Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J Neurosci. 2005;25:7278\u201387.","journal-title":"J Neurosci"},{"key":"169_CR2","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1073\/pnas.96.9.5274","volume":"96","author":"RB Knowles","year":"1999","unstructured":"Knowles RB, Wyart C, Buldyrev SV, Cruz L, Urbanc B, Hasselmo ME, Stanley HE, Hyman BT. Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 1999;96:5274\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"169_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","volume":"192","author":"DJ Selkoe","year":"2008","unstructured":"Selkoe DJ. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res. 2008;192:106\u201313.","journal-title":"Behav Brain Res"},{"key":"169_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, et al. Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med. 2008;14:837\u201342.","journal-title":"Nat Med"},{"key":"169_CR5","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1523\/JNEUROSCI.4456-09.2010","volume":"30","author":"HY Wu","year":"2010","unstructured":"Wu HY, Hudry E, Hashimoto T, Kuchibhotla K, Rozkalne A, Fan Z, Spires-Jones T, Xie H, Arbel-Ornath M, Grosskreutz CL, et al. Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation. J Neurosci. 2010;30:2636\u201349.","journal-title":"J Neurosci"},{"key":"169_CR6","doi-asserted-by":"publisher","first-page":"8740","DOI":"10.1073\/pnas.1206171109","volume":"109","author":"MA Busche","year":"2012","unstructured":"Busche MA, Chen X, Henning HA, Reichwald J, Staufenbiel M, Sakmann B, Konnerth A. Critical role of soluble amyloid-beta for early hippocampal hyperactivity in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2012;109:8740\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"169_CR7","doi-asserted-by":"publisher","first-page":"51S","DOI":"10.1007\/BF02982587","volume":"12","author":"KL Viola","year":"2008","unstructured":"Viola KL, Velasco PT, Klein WL. Why Alzheimer\u2019s is a disease of memory: the attack on synapses by A beta oligomers (ADDLs). J Nutr Health Aging. 2008;12:51S\u20137S.","journal-title":"J Nutr Health Aging"},{"key":"169_CR8","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1073\/pnas.0811698106","volume":"106","author":"RM Koffie","year":"2009","unstructured":"Koffie RM, Meyer-Luehmann M, Hashimoto T, Adams KW, Mielke ML, Garcia-Alloza M, Micheva KD, Smith SJ, Kim ML, Lee VM, et al. Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci U S A. 2009;106:4012\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"169_CR9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1749-6632.1994.tb44424.x","volume":"747","author":"JF Disterhoft","year":"1994","unstructured":"Disterhoft JF, Moyer Jr JR, Thompson LT. The calcium rationale in aging and Alzheimer\u2019s disease. Evidence from an animal model of normal aging. Ann N Y Acad Sci. 1994;747:382\u2013406.","journal-title":"Ann N Y Acad Sci"},{"key":"169_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.1994.tb44398.x","volume":"747","author":"ZS Khachaturian","year":"1994","unstructured":"Khachaturian ZS. Calcium hypothesis of Alzheimer\u2019s disease and brain aging. Ann N Y Acad Sci. 1994;747:1\u201311.","journal-title":"Ann N Y Acad Sci"},{"key":"169_CR11","doi-asserted-by":"crossref","unstructured":"Chakroborty S, Stutzmann GE. Calcium channelopathies and Alzheimer\u2019s disease: Insight into therapeutic success and failures. Eur J Pharmacol. 2013.","DOI":"10.1016\/j.ejphar.2013.11.012"},{"key":"169_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1474-9726.2007.00275.x","volume":"6","author":"MP Mattson","year":"2007","unstructured":"Mattson MP. Calcium and neurodegeneration. Aging Cell. 2007;6:337\u201350.","journal-title":"Aging Cell"},{"key":"169_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ceca.2005.06.021","volume":"38","author":"IF Smith","year":"2005","unstructured":"Smith IF, Green KN, LaFerla FM. Calcium dysregulation in Alzheimer\u2019s disease: recent advances gained from genetically modified animals. Cell Calcium. 2005;38:427\u201337.","journal-title":"Cell Calcium"},{"key":"169_CR14","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1471-4159.2011.07447.x","volume":"119","author":"LC Reese","year":"2011","unstructured":"Reese LC, Laezza F, Woltjer R, Taglialatela G. Dysregulated phosphorylation of Ca(2+)\/calmodulin-dependent protein kinase II-alpha in the hippocampus of subjects with mild cognitive impairment and Alzheimer\u2019s disease. J Neurochem. 2011;119:791\u2013804.","journal-title":"J Neurochem"},{"key":"169_CR15","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1523\/JNEUROSCI.6439-11.2012","volume":"32","author":"E Hudry","year":"2012","unstructured":"Hudry E, Wu HY, Arbel-Ornath M, Hashimoto T, Matsouaka R, Fan Z, Spires-Jones TL, Betensky RA, Bacskai BJ, Hyman BT. Inhibition of the NFAT pathway alleviates amyloid beta neurotoxicity in a mouse model of Alzheimer\u2019s disease. J Neurosci. 2012;32:3176\u201392.","journal-title":"J Neurosci"},{"key":"169_CR16","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0092-8674(01)00264-1","volume":"104","author":"G Malleret","year":"2001","unstructured":"Malleret G, Haditsch U, Genoux D, Jones MW, Bliss TV, Vanhoose AM, Weitlauf C, Kandel ER, Winder DG, Mansuy IM. Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin. Cell. 2001;104:675\u201386.","journal-title":"Cell"},{"key":"169_CR17","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1046\/j.1471-4159.1997.68041668.x","volume":"68","author":"US Kayyali","year":"1997","unstructured":"Kayyali US, Zhang W, Yee AG, Seidman JG, Potter H. Cytoskeletal changes in the brains of mice lacking calcineurin A alpha. J Neurochem. 1997;68:1668\u201378.","journal-title":"J Neurochem"},{"key":"169_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.neuron.2008.06.008","volume":"59","author":"KV Kuchibhotla","year":"2008","unstructured":"Kuchibhotla KV, Goldman ST, Lattarulo CR, Wu HY, Hyman BT, Bacskai BJ. Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron. 2008;59:214\u201325.","journal-title":"Neuron"},{"key":"169_CR19","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1126\/science.1162844","volume":"321","author":"MA Busche","year":"2008","unstructured":"Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, Haass C, Staufenbiel M, Konnerth A, Garaschuk O. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer\u2019s disease. Science. 2008;321:1686\u20139.","journal-title":"Science"},{"key":"169_CR20","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/ncomms1783","volume":"3","author":"C Grienberger","year":"2012","unstructured":"Grienberger C, Rochefort NL, Adelsberger H, Henning HA, Hill DN, Reichwald J, Staufenbiel M, Konnerth A. Staged decline of neuronal function in vivo in an animal model of Alzheimer\u2019s disease. Nat Commun. 2012;3:774.","journal-title":"Nat Commun"},{"key":"169_CR21","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1038\/nn.3199","volume":"15","author":"N Rudinskiy","year":"2012","unstructured":"Rudinskiy N, Hawkes JM, Betensky RA, Eguchi M, Yamaguchi S, Spires-Jones TL, Hyman BT. Orchestrated experience-driven Arc responses are disrupted in a mouse model of Alzheimer\u2019s disease. Nat Neurosci. 2012;15:1422\u20139.","journal-title":"Nat Neurosci"},{"key":"169_CR22","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1523\/JNEUROSCI.0462-04.2004","volume":"24","author":"EA Stern","year":"2004","unstructured":"Stern EA, Bacskai BJ, Hickey GA, Attenello FJ, Lombardo JA, Hyman BT. Cortical synaptic integration in vivo is disrupted by amyloid-beta plaques. J Neurosci. 2004;24:4535\u201340.","journal-title":"J Neurosci"},{"key":"169_CR23","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1126\/science.1113694","volume":"309","author":"K Santacruz","year":"2005","unstructured":"Santacruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M, Guimaraes A, DeTure M, Ramsden M, McGowan E, et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science. 2005;309:476\u201381.","journal-title":"Science"},{"key":"169_CR24","first-page":"349","volume":"299","author":"J Skoch","year":"2005","unstructured":"Skoch J, Hickey GA, Kajdasz ST, Hyman BT, Bacskai BJ. In vivo imaging of amyloid-beta deposits in mouse brain with multiphoton microscopy. Methods Mol Biol. 2005;299:349\u201363.","journal-title":"Methods Mol Biol"},{"key":"169_CR25","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/S0021-9258(19)83641-4","volume":"260","author":"G Grynkiewicz","year":"1985","unstructured":"Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440\u201350.","journal-title":"J Biol Chem"},{"key":"169_CR26","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/nprot.2006.172","volume":"1","author":"AE Palmer","year":"2006","unstructured":"Palmer AE, Tsien RY. Measuring calcium signaling using genetically targetable fluorescent indicators. Nat Protoc. 2006;1:1057\u201365.","journal-title":"Nat Protoc"},{"key":"169_CR27","doi-asserted-by":"publisher","first-page":"5298","DOI":"10.1523\/JNEUROSCI.0227-12.2012","volume":"32","author":"HY Wu","year":"2012","unstructured":"Wu HY, Hudry E, Hashimoto T, Uemura K, Fan ZY, Berezovska O, Grosskreutz CL, Bacskai BJ, Hyman BT. Distinct dendritic spine and nuclear phases of calcineurin activation after exposure to amyloid-beta revealed by a novel fluorescence resonance energy transfer assay. J Neurosci. 2012;32:5298\u2013309.","journal-title":"J Neurosci"},{"key":"169_CR28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1001\/archneur.57.1.100","volume":"57","author":"PD Mehta","year":"2000","unstructured":"Mehta PD, Pirttila T, Mehta SP, Sersen EA, Aisen PS, Wisniewski HM. Plasma and cerebrospinal fluid levels of amyloid beta proteins 1\u201340 and 1\u201342 in Alzheimer disease. Arch Neurol. 2000;57:100\u20135.","journal-title":"Arch Neurol"},{"key":"169_CR29","doi-asserted-by":"publisher","first-page":"10554","DOI":"10.1073\/pnas.0400417101","volume":"101","author":"T Nagai","year":"2004","unstructured":"Nagai T, Yamada S, Tominaga T, Ichikawa M, Miyawaki A. Expanded dynamic range of fluorescent indicators for Ca(2+) by circularly permuted yellow fluorescent proteins. Proc Natl Acad Sci U S A. 2004;101:10554\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"169_CR30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nrn1886","volume":"7","author":"MP Mattson","year":"2006","unstructured":"Mattson MP, Magnus T. Ageing and neuronal vulnerability. Nat Rev Neurosci. 2006;7:278\u201394.","journal-title":"Nat Rev Neurosci"},{"key":"169_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056970","volume":"8","author":"M Tesli","year":"2013","unstructured":"Tesli M, Skatun KC, Ousdal OT, Brown AA, Thoresen C, Agartz I, Melle I, Djurovic S, Jensen J, Andreassen OA. CACNA1C risk variant and amygdala activity in bipolar disorder, schizophrenia and healthy controls. PLoS ONE. 2013;8, e56970.","journal-title":"PLoS ONE"},{"key":"169_CR32","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/mp.2009.49","volume":"15","author":"EK Green","year":"2010","unstructured":"Green EK, Grozeva D, Jones I, Jones L, Kirov G, Caesar S, Gordon-Smith K, Fraser C, Forty L, Russell E, et al. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry. 2010;15:1016\u201322.","journal-title":"Mol Psychiatry"},{"key":"169_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2040-2392-3-18","volume":"3","author":"AT Lu","year":"2012","unstructured":"Lu AT, Dai X, Martinez-Agosto JA, Cantor RM. Support for calcium channel gene defects in autism spectrum disorders. Mol Autism. 2012;3:18.","journal-title":"Mol Autism"},{"key":"169_CR34","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/brain\/awt180","volume":"136","author":"AH Schapira","year":"2013","unstructured":"Schapira AH. Calcium dysregulation in Parkinson\u2019s disease. Brain. 2013;136:2015\u20136.","journal-title":"Brain"},{"key":"169_CR35","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.nbd.2011.04.007","volume":"43","author":"E Ilijic","year":"2011","unstructured":"Ilijic E, Guzman JN, Surmeier DJ. The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson\u2019s disease. Neurobiol Dis. 2011;43:364\u201371.","journal-title":"Neurobiol Dis"},{"key":"169_CR36","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1007\/s11064-010-0393-y","volume":"36","author":"I Bezprozvanny","year":"2011","unstructured":"Bezprozvanny I. Role of inositol 1,4,5-trisphosphate receptors in pathogenesis of Huntington\u2019s disease and spinocerebellar ataxias. Neurochem Res. 2011;36:1186\u201397.","journal-title":"Neurochem Res"},{"key":"169_CR37","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.tins.2008.06.005","volume":"31","author":"I Bezprozvanny","year":"2008","unstructured":"Bezprozvanny I, Mattson MP. Neuronal calcium mishandling and the pathogenesis of Alzheimer\u2019s disease. Trends Neurosci. 2008;31:454\u201363.","journal-title":"Trends Neurosci"},{"key":"169_CR38","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.neuint.2007.10.002","volume":"52","author":"L Bojarski","year":"2008","unstructured":"Bojarski L, Herms J, Kuznicki J. Calcium dysregulation in Alzheimer\u2019s disease. Neurochem Int. 2008;52:621\u201333.","journal-title":"Neurochem Int"},{"key":"169_CR39","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1111\/j.1582-4934.2009.00861.x","volume":"13","author":"KN Green","year":"2009","unstructured":"Green KN. Calcium in the initiation, progression and as an effector of Alzheimer\u2019s disease pathology. J Cell Mol Med. 2009;13:2787\u201399.","journal-title":"J Cell Mol Med"},{"key":"169_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080834","volume":"8","author":"KJ Kopeikina","year":"2013","unstructured":"Kopeikina KJ, Wegmann S, Pitstick R, Carlson GA, Bacskai BJ, Betensky RA, Hyman BT, Spires-Jones TL. Tau causes synapse loss without disrupting calcium homeostasis in the rTg4510 model of tauopathy. PLoS ONE. 2013;8, e80834.","journal-title":"PLoS ONE"},{"key":"169_CR41","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1073\/pnas.1318807111","volume":"111","author":"KV Kuchibhotla","year":"2014","unstructured":"Kuchibhotla KV, Wegmann S, Kopeikina KJ, Hawkes J, Rudinskiy N, Andermann ML, Spires-Jones TL, Bacskai BJ, Hyman BT. Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo. Proc Natl Acad Sci U S A. 2014;111:510\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"169_CR42","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","volume":"27","author":"GM Shankar","year":"2007","unstructured":"Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci. 2007;27:2866\u201375.","journal-title":"J Neurosci"},{"key":"169_CR43","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","volume":"101","author":"DM Walsh","year":"2007","unstructured":"Walsh DM, Selkoe DJ. A beta oligomers - a decade of discovery. J Neurochem. 2007;101:1172\u201384.","journal-title":"J Neurochem"},{"key":"169_CR44","doi-asserted-by":"publisher","first-page":"23818","DOI":"10.1074\/jbc.M701078200","volume":"282","author":"IH Cheng","year":"2007","unstructured":"Cheng IH, Scearce-Levie K, Legleiter J, Palop JJ, Gerstein H, Bien-Ly N, Puolivali J, Lesne S, Ashe KH, Muchowski PJ, Mucke L. Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J Biol Chem. 2007;282:23818\u201328.","journal-title":"J Biol Chem"},{"key":"169_CR45","first-page":"67","volume":"23","author":"DR Howlett","year":"2008","unstructured":"Howlett DR, Bowler K, Soden PE, Riddell D, Davis JB, Richardson JC, Burbidge SA, Gonzalez MI, Irving EA, Lawman A, et al. Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer\u2019s disease. Histol Histopathol. 2008;23:67\u201376.","journal-title":"Histol Histopathol"},{"key":"169_CR46","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R. Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30:572\u201380.","journal-title":"Ann Neurol"},{"key":"169_CR47","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1006\/neur.1996.0056","volume":"5","author":"ST DeKosky","year":"1996","unstructured":"DeKosky ST, Scheff SW, Styren SD. Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration. 1996;5:417\u201321.","journal-title":"Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration"},{"key":"169_CR48","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nrn987","volume":"3","author":"AE West","year":"2002","unstructured":"West AE, Griffith EC, Greenberg ME. Regulation of transcription factors by neuronal activity. Nat Rev Neurosci. 2002;3:921\u201331.","journal-title":"Nat Rev Neurosci"},{"key":"169_CR49","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ. Alzheimer\u2019s disease is a synaptic failure. Science. 2002;298:789\u201391.","journal-title":"Science"},{"key":"169_CR50","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1523\/JNEUROSCI.21-04-01327.2001","volume":"21","author":"JH Kim","year":"2001","unstructured":"Kim JH, Anwyl R, Suh YH, Djamgoz MB, Rowan MJ. Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo. J Neurosci. 2001;21:1327\u201333.","journal-title":"J Neurosci"},{"key":"169_CR51","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ceca.2011.02.001","volume":"49","author":"L Texido","year":"2011","unstructured":"Texido L, Martin-Satue M, Alberdi E, Solsona C, Matute C. Amyloid beta peptide oligomers directly activate NMDA receptors. Cell Calcium. 2011;49:184\u201390.","journal-title":"Cell Calcium"},{"key":"169_CR52","doi-asserted-by":"publisher","first-page":"29950","DOI":"10.1074\/jbc.M803992200","volume":"283","author":"F Pellistri","year":"2008","unstructured":"Pellistri F, Bucciantini M, Relini A, Nosi D, Gliozzi A, Robello M, Stefani M. Nonspecific interaction of prefibrillar amyloid aggregates with glutamatergic receptors results in Ca2+ increase in primary neuronal cells. J Biol Chem. 2008;283:29950\u201360.","journal-title":"J Biol Chem"},{"key":"169_CR53","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/nn1503","volume":"8","author":"EM Snyder","year":"2005","unstructured":"Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, Greengard P. Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci. 2005;8:1051\u20138.","journal-title":"Nat Neurosci"},{"key":"169_CR54","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.neuron.2009.05.012","volume":"62","author":"S Li","year":"2009","unstructured":"Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D. Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron. 2009;62:788\u2013801.","journal-title":"Neuron"},{"key":"169_CR55","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1083\/jcb.200706171","volume":"181","author":"KN Green","year":"2008","unstructured":"Green KN, Demuro A, Akbari Y, Hitt BD, Smith IF, Parker I, LaFerla FM. SERCA pump activity is physiologically regulated by presenilin and regulates amyloid beta production. J Cell Biol. 2008;181:1107\u201316.","journal-title":"J Cell Biol"},{"key":"169_CR56","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.neuron.2008.04.015","volume":"58","author":"KH Cheung","year":"2008","unstructured":"Cheung KH, Shineman D, Muller M, Cardenas C, Mei L, Yang J, Tomita T, Iwatsubo T, Lee VM, Foskett JK. Mechanism of Ca2+ disruption in Alzheimer\u2019s disease by presenilin regulation of InsP3 receptor channel gating. Neuron. 2008;58:871\u201383.","journal-title":"Neuron"},{"key":"169_CR57","doi-asserted-by":"publisher","first-page":"53524","DOI":"10.1074\/jbc.M408473200","volume":"279","author":"RA Christensen","year":"2004","unstructured":"Christensen RA, Shtifman A, Allen PD, Lopez JR, Querfurth HW. Calcium dyshomeostasis in beta-amyloid and tau-bearing skeletal myotubes. J Biol Chem. 2004;279:53524\u201332.","journal-title":"J Biol Chem"},{"key":"169_CR58","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1523\/JNEUROSCI.4367-12.2013","volume":"33","author":"A Demuro","year":"2013","unstructured":"Demuro A, Parker I. Cytotoxicity of intracellular abeta42 amyloid oligomers involves Ca2+ release from the endoplasmic reticulum by stimulated production of inositol trisphosphate. J Neurosci. 2013;33:3824\u201333.","journal-title":"J Neurosci"},{"key":"169_CR59","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.neulet.2012.04.008","volume":"516","author":"J Peng","year":"2012","unstructured":"Peng J, Liang G, Inan S, Wu Z, Joseph DJ, Meng Q, Peng Y, Eckenhoff MF, Wei H. Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice. Neurosci Lett. 2012;516:274\u20139.","journal-title":"Neurosci Lett"},{"key":"169_CR60","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.pneurobio.2016.01.001","volume":"144","author":"LM Osborn","year":"2016","unstructured":"Osborn LM, Kamphuis W, Wadman WJ, Hol EM. Astrogliosis: An integral player in the pathogenesis of Alzheimer\u2019s disease. Prog Neurobiol. 2016;144:121\u201341.","journal-title":"Prog Neurobiol"},{"key":"169_CR61","doi-asserted-by":"publisher","first-page":"31910","DOI":"10.1038\/srep31910","volume":"6","author":"A Drews","year":"2016","unstructured":"Drews A, Flint J, Shivji N, Jonsson P, Wirthensohn D, De Genst E, Vincke C, Muyldermans S, Dobson C, Klenerman D. Individual aggregates of amyloid beta induce temporary calcium influx through the cell membrane of neuronal cells. Sci Rep. 2016;6:31910.","journal-title":"Sci Rep"},{"key":"169_CR62","doi-asserted-by":"publisher","first-page":"E2518","DOI":"10.1073\/pnas.1306832110","volume":"110","author":"M Talantova","year":"2013","unstructured":"Talantova M, Sanz-Blasco S, Zhang X, Xia P, Akhtar MW, Okamoto S, Dziewczapolski G, Nakamura T, Cao G, Pratt AE, et al. Abeta induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss. Proc Natl Acad Sci U S A. 2013;110:E2518\u201327.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"169_CR63","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1126\/science.1169096","volume":"323","author":"KV Kuchibhotla","year":"2009","unstructured":"Kuchibhotla KV, Lattarulo CR, Hyman BT, Bacskai BJ. Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science. 2009;323:1211\u20135.","journal-title":"Science"},{"key":"169_CR64","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1196\/annals.1379.004","volume":"1097","author":"T Takano","year":"2007","unstructured":"Takano T, Han X, Deane R, Zlokovic B, Nedergaard M. Two-photon imaging of astrocytic Ca2+ signaling and the microvasculature in experimental mice models of Alzheimer\u2019s disease. Ann N Y Acad Sci. 2007;1097:40\u201350.","journal-title":"Ann N Y Acad Sci"},{"key":"169_CR65","doi-asserted-by":"publisher","first-page":"5422","DOI":"10.1038\/ncomms6422","volume":"5","author":"A Delekate","year":"2014","unstructured":"Delekate A, Fuchtemeier M, Schumacher T, Ulbrich C, Foddis M, Petzold GC. Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer\u2019s disease mouse model. Nat Commun. 2014;5:5422.","journal-title":"Nat Commun"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-017-0169-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13024-017-0169-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-017-0169-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T19:03:54Z","timestamp":1658862234000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-017-0169-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,21]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["169"],"URL":"https:\/\/doi.org\/10.1186\/s13024-017-0169-9","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,21]]},"assertion":[{"value":"13 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"27"}}